News

AbbVie Announces Significant Dividend Increase for Shareholders

AbbVie Announces Significant Dividend Increase for Shareholders

AbbVie Declares Quarterly Dividend

The board of directors at AbbVie Inc. (NYSE: ABBV) has announced a quarterly cash dividend of $1.55 per share. This decision reflects the company's ongoing commitment to providing value to its shareholders through dependable and substantial dividend distributions.

Details and Timeline for the Dividend

The announced dividend will be paid on November 15, 2024, to shareholders who are recorded as of the close of business on October 15, 2024. This timeline ensures that shareholders receive their dividends promptly.

Notable Dividend Growth

Since its establishment in 2013, AbbVie has impressively raised its dividend by more than 285 percent. This significant growth positions AbbVie among the distinguished companies on the S&P Dividend Aristocrats Index, which recognizes firms that have consistently increased their dividends for at least 25 years. This strong track record highlights the company's financial stability and dedication to rewarding its shareholders.

About AbbVie: Commitment to Innovation

AbbVie is committed to discovering and delivering innovative treatments and solutions that tackle serious health challenges both now and in the future. The company aims to make a meaningful impact on patients' lives across various therapeutic areas, including immunology, oncology, neuroscience, and eye care. Their extensive product range, which includes offerings from the Allergan Aesthetics portfolio, further emphasizes their dedication to advancing healthcare.

Engaging with AbbVie

If you're interested in learning more about AbbVie’s mission and initiatives, additional information is available on their official website. You can also connect with them on various social media platforms such as LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube, where they regularly share updates about new developments and offerings.

Frequently Asked Questions

What is the declared quarterly dividend amount by AbbVie?

The recent quarterly dividend declared by AbbVie is $1.55 per share.

When is the dividend payment date?

AbbVie plans to distribute the declared dividend on November 15, 2024.

What is AbbVie’s history with dividend increases?

Since its inception in 2013, AbbVie has increased its dividend by over 285 percent.

What index is AbbVie a part of due to its dividend performance?

AbbVie is a member of the S&P Dividend Aristocrats Index, which includes companies with a history of raising dividends for at least 25 consecutive years.

How can I connect with AbbVie for more information?

To get more information, you can visit AbbVie’s official website or follow them on social media platforms like LinkedIn and Facebook.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

GPRO, BWMN, DV Deals Scrutinized: Shareholder Impact?

Updated Category News Views 4

Questioning Fairness in Shareholder Deals There's a storm brewing in the world of mergers and acquisitions—and it's casting a shadow over the likes of GoPro, Bowman Consulting Group, and DoubleVerify. All three are under the legal microscope, with Halper Sadeh LLC, an investor rights firm, probing potential breaches of fiduciary responsibilities. It's always a...

Continue Reading
MIAX Launches New Fertilizer Futures Amid Market Fluctuations

Updated Category News Views 4

MIAX Sets Sights on Fertilizer Futures Out of the blue, we’ve got MIAX—one of the major players in financial markets—tossing their hat into the ring with fertilizer futures. They aren’t just playing around; they’ve launched four new physically-settled fertilizer futures contracts. You might wonder, why fertilizers? Hang tight, I'll tell you. MIAX is tapping into...

Continue Reading
Heineken Hit with €111M Judgment—A Precedent Set

Updated Category News Views 7

A Brew of Legal Consequences for Heineken If this isn't a financial wake-up call for the brewing giant, I don't know what is. In the latest twist of corporate accountability, the Amsterdam District Court has ordered Heineken and its Greek subsidiary, Athenian Brewery, to cough up a whopping €111 million. And we're not just talking pocket change—this ruling speaks...

Continue Reading
Dr. Anke Otto-Wolf's BEFORE Framework Revolutionizes SEL

Updated Category News Views 0

Teaching Kids to Catch Themselves: Introducing BEFORE Calling October Bullying Prevention Month seems quaint when you consider how often kids get shoved around, physically or emotionally. What’s surprising is how one simple word, ‘BEFORE,’ might just be the game-changer. Dr. Anke Otto-Wolf is betting big on it by unveiling the BEFORE Framework™. Imagine kids...

Continue Reading
Expert Vet Advice: When Pet Surgery Is Necessary

Updated Category News Views 0

Tough Calls: Knowing When Your Pet Needs Surgery Alright, when it comes to our furry companions, knowing when to opt for surgery ain't no walk in the park. It's a tricky balance, folks. Is that lump something to worry about? Will that limp heal on its own? HelloNation's recent piece dives into these questions, leveraging the expertise of Veterinarian Lorrie Riggs from...

Continue Reading
Advent Expands Middle East Presence with Abu Dhabi Office

Updated Category News Views 3

Advent's Bold Middle East Move Alright, let's get one thing straight: Advent isn't just tiptoeing into the Middle East—they're making a splash. On October 21, 2026, Advent unfurled a shiny new office in Abu Dhabi's ADGM, a prime international financial center. This ain't some tentative handshake. This move boldly asserts their ambition to deepen their foothold with...

Continue Reading
Long March Unity: Defying Odds with Shared Conviction

Updated Category News Views 4

Unlikely Unity Amidst Adversity Imagine facing a path so treacherous that every step could mean your last. That was the Long March for the Red Army—a grueling test not just of endurance, but of unity. This is the kind of story that makes you sit up and think about what drives people to stick together when everything is falling apart. The Red Army faced hellish...

Continue Reading
Bolt Teams with NVIDIA for Europe AV Expansion

Updated Category News Views 6

Racing Towards an Autonomous Future Well, hold onto your seats because the European roads will soon witness one hell of a technological trip—with an autonomous twist. Bolt, in cahoots with NVIDIA and Lucid, is plotting to roll out a massive fleet of autonomous vehicles just gearing up to hit the streets. The project's kicking off in Madrid in 2027 and aims to sprinkle...

Continue Reading
United Bancshares Delivers Strong Q3 Results, Boosts Dividend

Updated Category News Views 0

United Bancshares Shines in Third Quarter 2026 You don't always get handed a report that makes you grin over your coffee, but United Bancshares, Inc. (OTCQX:UBOH) has pulled off a strong showing for the third quarter of 2026. The bank's been on a tear, driving home an impressive $5.2 million in net income—that's $1.90 per share. Compare that against last year's $3.0...

Continue Reading
Salvi's Legal Titans Shine: 19 Super Lawyers Honored

Updated Category News Views 15

A Salute to Legal Prowess in Illinois Dusting off the headlines once again, Salvi, Schostok & Pritchard have played a winning hand, proving they're no pushover in Illinois' legal scene with a whopping 19 attorneys honored as Super Lawyers and Rising Stars for 2027. This isn't just any badge. We're talking about a pat on the back from peers in a fiercely competitive...

Continue Reading

Top 5 Most Recently Viewed Articles

Explore Insights from Precious Metals Virtual Investor Event

Updated Category News Views 184

Highlights of the Precious Metals & Critical Minerals Conference The much-anticipated Precious Metals and Critical Minerals Virtual Investor Conference is set to occur across three engaging days filled with presentations from an array of companies. This event not only brings together individual and institutional investors but also provides a unique platform for companies...

Continue Reading
Aequum Capital Elevates Eric Weisheit and Geno Ruggles to Partner

Updated Category News Views 108

Aequum Capital Elevates Leadership to New Heights Aequum Capital Financial LLC, a noted specialty finance lender, has recently announced an exciting development in its leadership team. The firm has promoted Eric Weisheit and Geno Ruggles to Partner, effective immediately. This promotion reflects the significant roles both individuals have played in the firm's progress and...

Continue Reading
Key Updates on Systemair's Nomination Committee Formation

Updated Category News Views 201

Systemair Nomination Committee Insights Systemair has made significant organizational strides, particularly concerning its nomination committee, which is fundamental in guiding the company's governance. As per the recent discussions among shareholders, it has been determined that the nomination committee will include representatives from three of the foremost shareholders...

Continue Reading
Illumina Sets New Records as Stock Reaches All-Time Highs

Updated Category News Views 78

Illumina Stock Achieves Notable Milestone In a remarkable display of resilience, Illumina (NASDAQ: ILMN), Inc. stock has hit a new 52-week high, reaching a price level of $144.18. This peak represents a significant milestone for the biotechnology company, renowned for its innovative genomic sequencing solutions. Over the past year, Illumina's stock has witnessed...

Continue Reading
BioCryst Pharmaceuticals Launches Groundbreaking HAE Treatment

Updated Category News Views 81

BioCryst Pharmaceuticals Celebrates FDA Approval The U.S. Food and Drug Administration (FDA) has granted approval for BioCryst Pharmaceuticals Inc.’s (NASDAQ: BCRX) New Drug Application (NDA) concerning an innovative oral pellet formulation of Orladeyo (berotralstat). This medication is specifically designed as a prophylactic therapy for pediatric patients aged 2 to...

Continue Reading